MGTX
MeiraGTx Holdings plc

950
Mkt Cap
$615.76M
Volume
198,842.00
52W High
$9.73
52W Low
$4.55
PE Ratio
-3.62
MGTX Fundamentals
Price
$7.31
Prev Close
$7.65
Open
$7.45
50D MA
$7.57
Beta
1.32
Avg. Volume
330,715.42
EPS (Annual)
-$2.12
P/B
-15.18
Rev/Employee
$87,346.46
$406.36
Loading...
Loading...
News
all
press releases
X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates
X4 Pharmaceuticals (XFOR) delivered earnings and revenue surprises of +38.89% and +53.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
More News
News Placeholder
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating
Zacks Research upgraded shares of MeiraGTx from a "strong sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·13d ago
News Placeholder
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading Volume - Time to Buy?
MeiraGTx (NASDAQ:MGTX) Sees Large Volume Increase - Here's Why...
MarketBeat·14d ago
News Placeholder
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
Editas (EDIT) delivered earnings and revenue surprises of +77.78% and +280.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
MeiraGTx (NASDAQ:MGTX) Stock Price Down 9.6% - Here's What Happened
MeiraGTx (NASDAQ:MGTX) Trading Down 9.6% - Here's Why...
MarketBeat·19d ago
News Placeholder
Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -28.71% and -3.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19d ago
News Placeholder
MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday
MeiraGTx (NASDAQ:MGTX) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...
MarketBeat·19d ago
News Placeholder
AnaptysBio, Inc. (ANAB) Q4 Earnings and Revenues Top Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of +78.53% and +28.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
TG Therapeutics (TGTX) Misses Q4 Earnings Estimates
TG Therapeutics (TGTX) delivered earnings and revenue surprises of -60.45% and +0.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·26d ago
News Placeholder
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of "Moderate Buy" from Analysts
MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the company, Marketbeat Ratings...
MarketBeat·1mo ago
<
1
2
...
>

Latest MGTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.